News
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. £10 million (c. $13 million) financing round.
4D Medicine raises £3.4m for unique biomaterial platform
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.
Double win for Cytecom at Medilink Awards
Warwick spinout Cytecom wins twice at Medilink Healthcare Business Awards
Patchs Health wins again
For the second year running, Patchs Health has been recognised at the Health Tech Digital Awards.
Warwick Acoustics completes £7m funding round
The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.
Clinical trials success for Medherant
Warwick spinout Medherant is pleased to announce preliminary results of trials of its testosterone patch for post menopausal women.
Warwick spinout Cytoswim receives FDA clearance
Cytoswim has received clearance from the U.S. Food and Drug Administration (FDA) for its novel SpermAlign device which helps select high quality sperm for use in Assistive Reproductive Techniques.
New Warwick spin-out company SEEV
Could e-voting be the future for general elections?
Revolutionising AI for cellular pathology
Warwick spin-out Histofy to revolutionise AI for cellular pathology.